SPL 3.13% 9.9¢ starpharma holdings limited

Bell Potter raises target to $2.20, page-5

  1. 2,062 Posts.
    lightbulb Created with Sketch. 303
    From the BP report summary --

    . COVID-19 has impacted recruitment in Phase 2 DEP-trials,
    however sites have reinitiated
    recruitment (London sites a bit slower than regional UK sites) and at this
    stage results from all the trials are expected within the next 6-7 months,
    which would serve as significant re-rating catalysts for the stock.

    I would suggest this info has come from SPL HQ
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.003(3.13%)
Mkt cap ! $40.82M
Open High Low Value Volume
9.8¢ 10.0¢ 9.7¢ $50.87K 510.1K

Buyers (Bids)

No. Vol. Price($)
1 180 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 101919 3
View Market Depth
Last trade - 15.20pm 05/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.